ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,737Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 559

$314K Total Retail Price of All Prescriptions

Rank: 111 out of 559

537 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,872 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 624 498 1 2
LISINOPRIL 365 344 2 1
SIMVASTATIN 254 239 3 3
HYDROCHLOROTHIAZIDE 226 193 4 8
OMEPRAZOLE 225 152 5 4
HYDROCODONE-ACETAMINOPHEN 220 151 S3 6 7
LOVASTATIN 167 144 7 10
ALENDRONATE SODIUM 167 150 7 13
AMLODIPINE BESYLATE 153 133 9 6
LOSARTAN POTASSIUM 150 135 10 14
ATENOLOL 147 121 11 15
METFORMIN HCL 139 121 12 5
GABAPENTIN 123 83 13 9
FUROSEMIDE 121 94 14 11
CITALOPRAM HBR 99 60 15 21
ZOLPIDEM TARTRATE 99 87 15 17
TRAZODONE HCL 99 67 15 28
METOPROLOL TARTRATE 97 92 18 12
TRIAMTERENE-HCTZ 94 77 19 47
OXYBUTYNIN CHLORIDE 81 68 20 62
FLUOXETINE HCL 80 63 21 37
OXYCODONE HCL 80 48 S2 21 32
PROAIR HFA 77 29 23 29
BACLOFEN 76 58 24 90
IBUPROFEN 75 40 25 30
RANITIDINE HCL 75 43 25 26
FLUTICASONE PROPIONATE 71 33 27 22
MIRTAZAPINE 69 69 28 61
SERTRALINE HCL 63 52 29 19
ESTRADIOL 63 25 R 29 117
TIZANIDINE HCL 62 34 31 166
FELODIPINE ER 61 59 32 72
CLONIDINE HCL 60 39 33 68
TRAMADOL HCL 60 43 33 27
VENLAFAXINE HCL ER 59 37 35 111
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 59 35 18
ADVAIR DISKUS 58 45 37 46
DICLOFENAC SODIUM 56 41 38 81
GLIPIZIDE 52 40 39 31
SYNTHROID 51 36 40 64
FENTANYL 51 32 S2 40 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.